https://clinicaltrials.gov/ct2/show/NCT02338999?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F28%2F2019&lupd_d=14
Condition : Systemic Lupus Erthematosus
Interventions : Radiation: PET/CT; Drug: Pioglitazone; Procedure: Vascular function studies
Sponsor : National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting
Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
NCT02338999
Thu, 15 Jan 2015 12:00:00 EST
>>> Updated February 11, 2019
